Log In
Print
BCIQ
Print
Print this Print this
 

Toca FC

  Manage Alerts
Collapse Summary General Information
Company Tocagen Inc.
DescriptionExtended-release oral antifungal 5-flucytosine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationBrain cancer
Indication DetailsTreat recurrent high grade glioma (HGG)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today